These are the first two certifications obtained by the factory, which was launched in mid-September, and which guarantee the quality and safety of the omega-3 oil produced there 

Grupo Natac (NAT), a biotechnology company specialised in the sustainable production of botanical extracts and omega-3 oils, has obtained the first two certifications for its omega-3 factory in As Somozas (Coruña), which was launched in mid-September. 

Specifically, the company has achieved the GMP+ and Halal seals, which reflects Natac’s continuous commitment to the highest standards of quality, food safety, and respect for the different cultural and religious traditions in its production processes. 

The GMP+ certificate recognises that the As Somozas factory complies with strict international standards of quality and safety in the manufacture of products. This seal is especially relevant for the feed and food industry, ensuring that the production and factory management processes are adequate to deliver products that not only comply with local regulations but also surpass international expectations. 

On the other hand, the Halal certification guarantees that the omega-3 manufactured at the A Coruña factory complies with the requirements established by Islamic law, which allows Natac to expand its presence in Muslim consumer markets, both nationally and internationally. This seal ensures that the products meet the purity and traceability requirements necessary for this niche market. 

Antonio Delgado, Natac’s CEO, highlights: “With these first two certificates we are responding to our customers’ needs, and we position ourselves as a reference in the sector by being at the forefront of responsible production. These seals allow us to continue growing and offering products that meet the highest quality and safety requirements.” 

About Grupo Natac 

Grupo Natac is a leading biotechnology company specialised in the sustainable production of botanical extracts and functional oils with proven health benefits. Natac researches, develops, manufactures, and sells natural ingredients to be used in food supplements, pharmaceuticals, functional food, pet food, and cosmetics. The group has an extensive product portfolio (more than 180 products developed), eight international patents, and has executed more than 40 national and European R&D&I projects. Natac began trading on the BME Growth in the third quarter of 2023, the second-largest capital expansion in the history of this stock market.